ADIL Insider Trading Activity and SEC Form 4 Filings
ADIL insider trading summary
Over the past 12 months, insiders at Adial Pharmaceuticals, Inc. (ADIL) reported 3 open-market purchases worth $74K by 1 insider and no sales on SEC Form 4. Net insider buying was $74K.
Latest ADIL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Coastlands Capital LP | 10% Owner | Buy | $3K (1,233 @ $2.75) |
| Jul 14, 2026 | Coastlands Capital LP | 10% Owner | Buy | $5K (2,000 @ $2.65) |
| Jun 29, 2026 | Coastlands Capital LP | 10% Owner | Buy | $65K (25,000 @ $2.60) |
| Sep 29, 2023 | Kevin Schuyler | Director | Buy | $2K (700 @ $2.74) |
| Dec 30, 2021 | James W. Newman Jr. | Director | Buy | $27K (10,000 @ $2.66) |
| Dec 30, 2021 | James W. Newman Jr. | Director | Buy | $14K (5,000 @ $2.72) |
| Dec 30, 2021 | James W. Newman Jr. | Director | Buy | $27K (10,000 @ $2.71) |
| Nov 30, 2021 | William B. Stilley III | Chief Executive Officer | Buy | $29K (10,600 @ $2.75) |
| Nov 29, 2021 | William B. Stilley III | Chief Executive Officer | Buy | $26K (10,000 @ $2.59) |
| Nov 26, 2021 | James W. Newman Jr. | Director | Buy | $29K (10,000 @ $2.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.